Corvus Pharmaceuticals Inc (CRVS)
Net Income Growth
-124.54%
Quarterly · Period ending:
CRVS Net Income Growth
Year-over-year change vs the same period a year earlier
Latest reported-124.54%period ending
Latest reported-124.54%period ending
CRVS Quarterly Net Income YoY % (-3821.43% → -124.54%)
Year-over-year change
High-resolution chart · PNG
CRVS net income growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Net Income Growth |
|---|---|
| -124.5436% | |
| -190.1205% | |
| -1.7172% | |
| 74.7445% | |
| -87.6584% | |
| 366.4971% | |
| -82.0682% | |
| -570.2833% | |
| 34.461% | |
| 27.588% | |
| 32.2229% | |
| 59.5442% | |
| 22.2408% | |
| 5.1103% | |
| -6.2798% | |
| -38.9581% | |
| 28.8376% | |
| 28.3506% | |
| -133.7734% | |
| -8.9526% | |
| -10.753% | |
| 10.4755% | |
| 347.5514% | |
| 10.9778% | |
| 18.2386% | |
| -11.0968% | |
| -5.1194% | |
| -4.82% | |
| -11.5811% | |
| 18.5861% | |
| 11.9038% | |
| 17.4491% | |
| 22.3617% | |
| 10.8194% | |
| -7.6042% | |
| -23.502% | |
| -73.2909% | |
| -152.6548% | |
| -83.5734% | |
| -226.7851% | |
| 57.2707% | |
| -231.7825% | |
| -3,821.4286% |